A recent announcement by Eli Lilly suggests that the company understands the economic conundrum some patients face. Per a recent press release, Lilly is now offering a four-week supply of 2.5 milligram Zepbound vials for $399, as well as a 5 mg dose for $549.

Weight loss drugs are all the rage right now. From the more popular options like Mounjaro or Ozempic – which is technically a diabetes medication that also helps with weight management – to emerging medications like WeGovy and Zepbound,

Patients will have to draw the medication from a syringe, similar to what people who take compounded weight management drugs have to do. The vials are a cheaper alternative for people who don’t have health insurance,